-
Mannin and Cyclica Enter JV to Rapidly Develop COVID-19 Drugs
Mannin-Cyclica JV to rapidly develop drugs to treat COVID-19 patients using the Tie2 receptor expertise of Mannin and Cyclica’s AI-augmented drug discovery platform The projects will include small molecule treatments to treat infectious diseases including COVID-19 and influenza Toronto, Canada and Leipzig, Germany, April 20th, 2020 – Mannin Research has entered a joint venture (JV) between Mannin GmbH, a German Mannin subsidiary, and Cyclica Inc. The Mannin – Cyclica...
